Stratipath is using deep learning analysis of histopathological images to bring precision oncology to all cancer patients.
Stockholm
Joined June 2022
- Tweets103
- Following201
- Followers69
- Likes45
Pinned Tweet
Stratipath Breast is the first EU regulatory compliant solution for risk stratification of breast cancer using AI-based precision diagnostics to analyse cancer tissue, and enabling identification of patients with increased risk of disease progression. stratipath.com/stratipath_br…
Stratipath retweeted
🎥 Behind the scenes of our interview at #ESMOBreast2026 with Johan Hartman, a Professor and research group leader at @karolinskainst, and Co-founder of @stratipath.
In the next coming weeks, we'll be publishing Dr Hartman's insights on:
- His poster presentation titled: ‘molecular and phenotypic characterization of breast cancers with low, intermediate and high estrogen receptor expression’
- Next steps for his research
- How he would like to see AI-driven diagnostics advance breast cancer diagnosis
- The future of precision pathology
So stay tuned!... 👀
Stratipath retweeted
Dr. Johan Hartman and Emelie Karlsson of Karolinska Institutet present Stratipath Breast, a regulatory-approved AI solution that analyzes H&E-stained slides to support risk stratification in early-stage breast cancer. Hear their presentation at PathVisions25.
Stratipath retweeted
Every patient deserves faster, more informed decisions - and with AI, we're making it happen.
Annica Ericson, at @stratipath, shares how Stratipath Breast is changing cancer diagnostics in Sweden & now via Diagnexia in the UK.
More info: news.diagnexia.com/4eVhl8f
Contact us: [email protected]
#AIinHealthcare #BreastCancer #Diagnexia #Stratipath #DigitalPathology
Stratipath retweeted
Delighted to have Stratipath as a GENIAL partner! With their expertise in diagnostic AI solutions, they’ll implement prognostic models and ensure top-notch quality control. Learn more about them: stratipath.com/ 🤖🔬 #GENIALProject #AI #Stratipath
SwAIPP 2, has been funded by Sweden’s innovation agency, @vinnovase . We at Stratipath are proud to be partners in this consortium alongside leaders in academia, healthcare, and industry. Read about the project in Oncology Sweden. onkologiisverige.se/swaipp2-…
Stratipath co-founder Johan Hartman appeared as an expert guest on Swedish @Nyheterna, alongside @susannedieroff, Chair of @brostcancer. Focusinh on the breast cancer report and the pressing issue of unequal access to precision diagnostics. tv4play.se/klipp/3015182c762…
In a recent interview with Impact Loop, Stratipath co-founder Johan Hartman shared exciting insights into Stratipath’s role in transforming cancer care:
Read the full article (in Swedish): lnkd.in/ghmuCK56
We had the pleasure of welcoming @bradloncar from @BiotechTVHQ to Stockholm, where he caught up with our co-founder and CMO Professor Johan Hartman. They delved into the pioneering innovation coming out of @karolinskainst and the journey of developing Stratipath.
From Stockholm: The co-founder of Stockholm's @stratipath talks digital pathology and what it was like to spin out of the prestigious @karolinskainst.
Full video: biotechtv.com/post/stratipat…
If you’re attending the #ecp2024, make sure to catch the inspiring session by Stratipath co-founder, Professor Johan Hartman, “How AI will save us tomorrow: development of AI algorithms in pathology,”
Time: 15:20 CET, Location: Spadolini 4, Track: SPEC-08
Stratipath retweeted
Roche announced expansion of its digital pathology open environment to support cancer research & diagnostics by integrating > 20 AI algorithms from 8 new collaborators incl @OwkinScience @Lunit_AI @qritive @stratipath @SonraiLtd @deepbio_ai, DiaDeep & Mindpeak
Stratipath retweeted
Roche, Stratipath Ink Deal to Distribute Breast Cancer Digital Pathology Solution precisionmedicineonline.com/…
Press release - Stratipath and Roche Join Forces to Help Expand Access to AI-Powered Precision Diagnostics. In this non-exclusive collaboration, Roche will have the distribution rights to the integrated Stratipath solution, Stratipath Breast.
stratipath.com/stratipath-an…
In collaboration with @iBreastBook , Johan Hartman, co-founder of Stratipath, recently participated in a webinar focused on predictive and prognostic tools in breast cancer care.
youtube.com/watch?v=vLx1PlBS…
Recently published: A new validation study on the prognostic performance of Stratipath Breast—the first AI-based CE-marked medical device for risk stratification of breast cancer using routine H&E images. Great work @AbhiSharma1423
stratipath.com/a-new-validat…
Stratipath retweeted
I'm glad to share the second research article from my PhD thesis: "Validation of an AI-based solution for breast cancer risk stratification using routine digital histopathology images"
breast-cancer-research.biome…
Stratipath retweeted
You seem to be curious about our precision medicine AI portfolio, so our Chief Strategy Officer @Nate_Buchbinder is here to unpack it.
Learn more: bit.ly/3y92rKN
@IbexMedAx, @Visiopharm, @stratipath,
DoMore Diagnostics, Mindpeak, @nucleai_ai
Stratipath retweeted
We've made it easier for you to learn about our precision medicine AI portfolio!
See our new site page for the diagnostic and research applications available on Concentriq and in our pipeline from Proscia and our partners @IbexMedAx, @Visiopharm, DoMore Diagnostics, @stratipath, Mindpeak, and @nucleai_ai.
bit.ly/3y92rKN
Last night, Stratipath was honored with the Dream Award at the Techarenan Challenge in Almedalen.
The Dream Award is given to the company that has approached its industry with both heart and mind to bring about revolutionary change.
lnkd.in/dqFXs59M
Today at 14.10 (Swedish time) Stratipath CMO Professor Johan Hartman is a panelist at Folkhälsodalen at Almedalen week, Visby. The seminar is titled ”No Precision Medicine without Pathology”
The talk will be in Swedish and is possible to view here >> api.screen9.com/preview/npvs…?
Join us at @ESMO Breast! Stratipath’s team, including CEO Fredrik Wetterhall, CMO Johan Hartman, and Customer Service Specialist Emelie Karlsson, will be there to discuss our AI-based risk profiling tool, Stratipath Breast. Reach out to connect with us!
#ESMOBreast #AIDiagnostics